Logos Global Management LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Logos Global Management LP disclosed 53 US equity positions worth $892.7m in its Q3 2024 13F filing. The largest position was IDYA at 7.5% of the reported book, followed by GPCR and RVMD.
What did Logos Global Management LP own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 7.5% | $66.5m | 2,100,000 | – | |
| 2 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 6.1% | $54.9m | 1,250,000 | – | |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 6.1% | $54.4m | 1,200,000 | – | |
| 4 | IRON DISC MEDICINE INC | Healthcare | 5.1% | $45.9m | 935,000 | – | |
| 5 | JANX JANUX THERAPEUTICS INC | Healthcare | 5.1% | $45.4m | 1,000,000 | – | |
| 6 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 4.3% | $38.3m | 3,208,875 | – | |
| 7 | PCVX VAXCYTE INC | Healthcare | 3.8% | $34.3m | 300,000 | – | |
| 8 | IMVT IMMUNOVANT INC | Healthcare | 3.5% | $31.4m | 1,100,000 | – | |
| 9 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 3.4% | $30.6m | 900,000 | – | |
| 10 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 3.4% | $30.4m | 3,500,000 | – | |
| 11 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 3.4% | $30.0m | 750,000 | – | |
| 12 | ERAS ERASCA INC | Healthcare | 3.3% | $29.8m | 10,900,000 | – | |
| 13 | MERUS N V | 3.2% | $28.7m | 575,000 | – | ||
| 14 | LKFT GALAPAGOS NV | Healthcare | 2.6% | $23.0m | 800,000 | – | |
| 15 | AKERO THERAPEUTICS INC | 2.6% | $23.0m | 800,000 | – | ||
| 16 | DSGN DESIGN THERAPEUTICS INC | Healthcare | 2.5% | $22.7m | 4,217,627 | – | |
| 17 | VERA VERA THERAPEUTICS INC | Healthcare | 2.5% | $22.1m | 500,000 | – | |
| 18 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.4% | $21.6m | 2,000,000 | – | |
| 19 | CYTK CYTOKINETICS INC | Healthcare | 2.4% | $21.1m | 400,000 | – | |
| 20 | BCAX BICARA THERAPEUTICS INC | 2.3% | $20.4m | 800,000 | – | ||
| 21 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 2.1% | $18.7m | 150,000 | – | |
| 22 | ANNX ANNEXON INC | Healthcare | 1.7% | $15.4m | 2,600,000 | – | |
| 23 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 1.7% | $15.4m | 1,100,000 | – | |
| 24 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 1.4% | $12.6m | 495,000 | – | |
| 25 | BEAM BEAM THERAPEUTICS INC | Healthcare | 1.4% | $12.2m | 500,000 | – | |
| 26 | EWTX EDGEWISE THERAPEUTICS INC | 1.3% | $12.0m | 450,000 | – | ||
| 27 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 1.3% | $11.3m | 500,000 | – | |
| 28 | YMABUSD Y-MABS THERAPEUTICS INC | 1.2% | $10.5m | 800,000 | – | ||
| 29 | ARVN ARVINAS INC | Healthcare | 1.1% | $9.9m | 400,000 | – | |
| 30 | TRVI TREVI THERAPEUTICS INC | Healthcare | 1.0% | $9.2m | 2,750,000 | – | |
| 31 | NUVALENT INC | 0.9% | $7.7m | 75,000 | – | ||
| 32 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.8% | $7.3m | 1,159,030 | – | |
| 33 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.7% | $6.3m | 257,330 | – | |
| 34 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.7% | $6.0m | 325,000 | – | |
| 35 | SYRE SPYRE THERAPEUTICS INC | 0.7% | $5.9m | 200,000 | – | ||
| 36 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.6% | $5.7m | 160,000 | – | |
| 37 | CATBUSD ASTRIA THERAPEUTICS INC | 0.6% | $5.5m | 500,000 | – | ||
| 38 | HELP CYBIN INC | 0.6% | $5.3m | 600,000 | – | ||
| 39 | ENGENE HOLDINGS INC | 0.6% | $5.3m | 800,000 | – | ||
| 40 | AVTX AVALO THERAPEUTICS INC | Healthcare | 0.6% | $5.1m | 539,079 | – | |
| 41 | LCTX LINEAGE CELL THERAPEUTICS IN | 0.5% | $4.5m | 5,000,000 | – | ||
| 42 | RAPP RAPPORT THERAPEUTICS INC | 0.5% | $4.1m | 208,910 | – | ||
| 43 | SLN SILENCE THERAPEUTICS PLC | 0.4% | $3.6m | 200,000 | – | ||
| 44 | ATYR ATYR PHARMA INC | Healthcare | 0.4% | $3.5m | 2,000,000 | – | |
| 45 | NXTC NEXTCURE INC | 0.4% | $3.4m | 2,500,000 | – | ||
| 46 | AVU0 ADVERUM BIOTECHNOLOGIES INC | 0.3% | $2.9m | 416,666 | – | ||
| 47 | ARTV ARTIVA BIOTHERAPEUTICS INC | 0.2% | $2.1m | 145,089 | – | ||
| 48 | UNCY UNICYCIVE THERAPEUTICS INC | 0.2% | $2.1m | 5,078,927 | – | ||
| 49 | ALLKGUSD ALLAKOS INC | 0.2% | $1.9m | 2,900,000 | – | ||
| 50 | NMRA NEUMORA THERAPEUTICS INC. | Healthcare | 0.1% | $1.3m | 100,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.